voriconazole · Pf Prism Cv · NDA 021266, 021267, 021630
Vfend
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220078, Zhejiang Novus · 021267-001Approved 5 May 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 220043, Hainan Poly Pharm · 021267-001Approved 14 Nov 2025Detected 25 Oct 2026Historical import
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021266 · 001 · RLD | tablet, oral | 50MG | open |
| 021266 · 002 · RLD | tablet, oral | 200MG | open |
| 021267 · 001 · RLD | powder, intravenous | 200MG/VIAL | open |
| 021630 · 001 · RLD | for suspension, oral | 200MG/5ML | open |